Supersapiens and the INEOS Grenadiers Announce Innovation Partnership
The seven-time Tour de France winning cycling team is using the first direct-to-consumer energy management system powered by the Abbott Libre Sense Glucose Sport Biosensor
Supersapiens and the INEOS Grenadiers announce innovation partnership that will allow their athletes to have real-time glucose visibility
Atlanta, Georgia, Oct. 02, 2020 (GLOBE NEWSWIRE) — Supersapiens, a sports technology company empowering energy management to sustain peak athletic performance, is partnering with the INEOS Grenadiers as part of a cutting-edge initiative that will allow their athletes to have real-time glucose visibility through the Abbott Libre Sense Glucose Sport Biosensor.
Supersapiens is built for athletes by athletes with a combined 30+ years of experience at the toughest level of sports. In a partnership with global healthcare leader Abbott, Supersapiens is bringing glucose monitoring technology to Europe designed specifically for athletes.
“Sir Dave Brailsford has a proven track record showing attention to detail delivers results. The INEOS Grenadiers are data-focused and consistently on the forefront of science and technology in the peloton. I greatly respect Dave and am honored to call the INEOS Grenadiers a partner,” said Phil Southerland, founder and CEO of Supersapiens and former professional cyclist.
Through the Supersapiens partnership, the INEOS Grenadiers will have real-time glucose visibility through the Abbott Libre Sense Glucose Sport Biosensor. Combined with the Supersapiens app, riders and coaches will be able to retrospectively analyze data, finetune fueling strategies, and establish a correlation between glucose levels and athletic performance.
“There is constant change and evolution in technology, and we are always looking for partners who can help us find the latest data-driven solutions. Supersapiens is a company built by athletes for athletes, so they understand the importance of energy management and